NCT02866825View on ClinicalTrials.gov

Studying Complement Inhibition in Complex Cardiac Surgery

PHASE2CompletedINTERVENTIONAL

Enrollment

116

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

January 31, 2017

Conditions

Systemic Inflammatory Response SyndromeC.Surgical Procedure; Cardiac

Interventions

BIOLOGICAL

IFX-1

BIOLOGICAL

Placebo

Trial Locations (10)

Unknown

Study Site, Aachen

Study Site, Dortmund

Study Site, Dresden

Study Site, Freiburg im Breisgau

Study Site, Heidelberg

Study Site, Jena

Study Site, Kiel

Study Site, Leipzig

Study Site, Trier

Study Site, Tübingen

Sponsors

Lead Sponsor

All Listed Sponsors

lead

InflaRx GmbH

INDUSTRY

NCT02866825 - Studying Complement Inhibition in Complex Cardiac Surgery | Biotech Hunter | Biotech Hunter